Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

New Brain Health Guidelines – What GPs Can Do

Navigating Perimenopause and Menopause – Managing Weight, Health and Wellbeing in General Practice

Autism & Mental Health Comorbidities

Pharmacogenomics in General Practice

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne